L2 Diagnostics

L2 is a premier translational research company to meet the most pressing unmet medical needs. L2 was founded in 1998 as a provider of novel diagnostic services for systemic lupus erythematosus and Lyme disease. The company rapidly evolved a new emphasis on developing novel diagnostic tools in a number of areas, discovering new vaccines and the development of small molecule therapeutics. Our current research activity is summarized on the Research page on this site.